MedPath

EVERITT, HAZEL

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 4
1 (100.0%)

Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)

Phase 4
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Drug: placebo
Behavioral: CBT website with minimal support
Behavioral: No website
Behavioral: CBT website with support
First Posted Date
2009-07-08
Last Posted Date
2021-04-30
Lead Sponsor
Hazel Everitt
Target Recruit Count
135
Registration Number
NCT00934973
Locations
πŸ‡¬πŸ‡§

University of Southampton, Southampton, Hampshire, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.